
Gwendolyn Wu
ReporterGwendolyn is a reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.
118 articles by Gwendolyn Wu
-
Novo Nordisk, Evotec partner in metabolic disease drug discovery pact
Sept. 26, 2023 -
Intarcia’s diabetes drug-device combo voted down again by FDA panel
Sept. 21, 2023 -
Genentech takes up a deal to make ‘molecular glue’ drugs
Sept. 20, 2023 -
Startup Airna emerges from stealth to bring RNA editing to a rare disease
Sept. 19, 2023 -
RayzeBio, Neumora price some of biotech’s largest IPOs this year
Sept. 14, 2023 -
Flagship-backed Generate raises $273M as its first drugs move to the clinic
Sept. 14, 2023 -
With latest fundraise, Rome Therapeutics works to drug the ‘dark genome’
Sept. 12, 2023 -
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
Sept. 6, 2023 -
Star Therapeutics adds another $90M to grow its galaxy of drug startups
Sept. 5, 2023 -
Intarcia, a former biotech unicorn, gets new life with startup deal
Aug. 30, 2023 -
Superluminal draws RA Capital, Nvidia as investors in GPCR drug hunt
Aug. 28, 2023 -
Neumora, a richly funded brain drug developer, readies for an IPO
Aug. 25, 2023 -
Radiopharmaceutical drugmaker RayzeBio signals plans to go public
Aug. 25, 2023 -
Foundery, a new biotech venture firm, sets out to speed early immune drug research
Aug. 22, 2023 -
In a year with few biotech IPOs, ‘crossover’ financings are hard to find
Aug. 16, 2023 -
Alltrna raises $109M for ‘transfer RNA’ drug vision
Aug. 9, 2023 -
Steve Jobs’ son raises $200M for cancer-focused venture fund
Aug. 2, 2023 -
Early-stage biotech funding on pace to drop 40% in 2023, HSBC report shows
July 28, 2023 -
European VC Medicxi raises $400M for ‘asset-centric’ biotech investing
July 27, 2023 -
Nexo allies with MD Anderson in pursuit of covalent cancer drugs
July 26, 2023 -
Editas names Biogen veteran as top scientist in latest executive change
July 24, 2023 -
Pfizer, Flagship join forces to hunt for 10 new drugs
July 18, 2023 -
Sanofi expands research deal with gene editing startup Scribe
July 17, 2023 -
Apogee, Sagimet price IPOs in positive sign for sluggish biotech market
July 14, 2023 -
Rupert Vessey, former Bristol Myers exec, to join Flagship as top scientist
July 13, 2023